Clinical aspects and molecular mechanisms in large granular lymphocyte (LGL) leukemia - IDeAL study

Clinical aspects and molecular mechanisms in large granular lymphocyte (LGL) leukemia - IDeAL study - Research into clinical aspects and molecular mechanisms in LGL leukemia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55452

Enrollment

150

Registered

2018-07-05

Start date

2019-07-24

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood cancer Large granular lymphocyte leukemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with LGL leukemia / lymphoproliferation

Exclusion criteria

Exclusion criteria: No consent

Design outcomes

Primary

Measure	Time frame
Observational study without formal endpoints. At the end of this study, more insights will be gained about the following parameters: • fenotypical features • clonal TCR repertoire at DNA / RNA and possibly functional level • (epi)genetic and transcriptional patterns • (auto)antibodies and cytokines	—

Countries

Netherlands

Outcome results